Oxford Pharmascience Group Stock Price, News & Analysis (LON:OXP)

GBX 1.50 1.50 (Infinity)
(As of 01/23/2018 04:00 PM ET)
Previous CloseGBX 1.50
Today's RangeGBX 1.46 - GBX 1.48
52-Week RangeGBX 1.12 - GBX 3.61
Volume1.00 million shs
Average Volume118,914 shs
Market Capitalization£18.25 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Oxford Pharmascience Group (LON:OXP)

Oxford Pharmascience Group logoOxford Pharmascience Group plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in re-developing medicines. The Company primarily engages in research and development activities based around its core technology platforms and focuses on commercializing the related products to pharmaceutical organizations. It operates through one segment, being the development and commercialization of drug products from proprietary technology platforms. The Company operates in three main geographic areas, such as the United Kingdom, Middle East and Brazil. The Company is primarily focused on commercialization efforts for its compounds OXPzero Ibuprofen and OXPzero Naproxen and in regulatory, technical and clinical activities in support of these assets. It is focused on establishing a number of commercial partnerships that demonstrate the commercial feasibility of the technology. The Company's subsidiaries include Oxford Pharmascience Limited and Oxford Nutra Limited.

Receive OXP News and Ratings via Email

Sign-up to receive the latest news and ratings for OXP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Shell Companies
Sub-IndustryN/A
SectorShell Companies
SymbolLON:OXP
CUSIPN/A
Phone+44-20-75545875

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net Margins-318.12%
Return on Equity-12.30%
Return on Assets-12.18%

Miscellaneous

EmployeesN/A
Outstanding Shares1,210,000,000

Oxford Pharmascience Group (LON:OXP) Frequently Asked Questions

What is Oxford Pharmascience Group's stock symbol?

Oxford Pharmascience Group trades on the London Stock Exchange (LON) under the ticker symbol "OXP."

Who are some of Oxford Pharmascience Group's key competitors?

Who are Oxford Pharmascience Group's key executives?

Oxford Pharmascience Group's management team includes the folowing people:

  • Marcelo Leonardo Bravo, Chief Executive Officer, Executive Director
  • Christopher Hill, Chief Financial Officer, Executive Director, Company Secretary
  • David Robert Norwood, Non-Executive Chairman of the Board (Age 48)
  • James Nicholas Gerald White, Non-Executive Deputy Chairman of the Board
  • John Geoffery Goddard, Independent Non-Executive Director
  • Karl Robertson Van Horn, Independent Non-Executive Director (Age 80)

How do I buy Oxford Pharmascience Group stock?

Shares of Oxford Pharmascience Group and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Oxford Pharmascience Group's stock price today?

One share of Oxford Pharmascience Group stock can currently be purchased for approximately GBX 1.50.

How big of a company is Oxford Pharmascience Group?

Oxford Pharmascience Group has a market capitalization of £18.25 million.

How can I contact Oxford Pharmascience Group?

Oxford Pharmascience Group's mailing address is Camden, 2 Royal College Street, LONDON, NW1 0NH, United Kingdom. The company can be reached via phone at +44-20-75545875.


MarketBeat Community Rating for Oxford Pharmascience Group (OXP)

Community Ranking:  1.0 out of 5 (star)
Outperform Votes:  41 (Vote Outperform)
Underperform Votes:  163 (Vote Underperform)
Total Votes:  204
MarketBeat's community ratings are surveys of what our community members think about Oxford Pharmascience Group and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Oxford Pharmascience Group (LON:OXP) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: N/AN/AN/AN/A
Consensus Rating Score: N/AN/AN/AN/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A

Oxford Pharmascience Group (LON:OXP) Consensus Price Target History

Price Target History for Oxford Pharmascience Group (LON:OXP)

Oxford Pharmascience Group (LON:OXP) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
5/9/2017N+1 SingerReiterated RatingcorporateView Rating Details
7/21/2016Beaufort SecuritiesDowngradeHoldView Rating Details
(Data available from 1/23/2016 forward)

Earnings

Earnings History for Oxford Pharmascience Group (LON:OXP)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Oxford Pharmascience Group (LON:OXP) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Oxford Pharmascience Group (LON:OXP)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Oxford Pharmascience Group (LON OXP)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Oxford Pharmascience Group (LON OXP) News Headlines

Source:
DateHeadline
Completion of Demerger - London South East (blog)Completion of Demerger - London South East (blog)
www.lse.co.uk - December 23 at 5:50 AM
Oxford Pharmascience Gets US Regulatory Boost For OXPZero ProductOxford Pharmascience Gets US Regulatory Boost For OXPZero Product
www.morningstar.co.uk - November 29 at 5:01 PM
Who Are The Major Shareholders Of Oxford Pharmascience Group Plc (AIM:OXP)?Who Are The Major Shareholders Of Oxford Pharmascience Group Plc (AIM:OXP)?
finance.yahoo.com - October 27 at 9:18 AM
Oxford Pharmascience Group Plc (OXP) to Release Earnings on TuesdayOxford Pharmascience Group Plc (OXP) to Release Earnings on Tuesday
www.americanbankingnews.com - August 29 at 1:34 AM
Further Update re: OXPzero Ibuprofen Programmes - London South East (registration) (blog)Further Update re: OXPzero Ibuprofen Programmes - London South East (registration) (blog)
www.lse.co.uk - June 8 at 8:00 PM
Oxford Pharmascience Well-Funded For Development As 2016 Loss NarrowsOxford Pharmascience Well-Funded For Development As 2016 Loss Narrows
www.morningstar.co.uk - March 10 at 9:11 AM
Oxford Pharmascience Interim Loss Narrows As New Products Near LaunchOxford Pharmascience Interim Loss Narrows As New Products Near Launch
www.morningstar.co.uk - September 8 at 10:30 AM
Half Year 2016 Oxford Pharmascience Group PLC Earnings Release - Time Not SuppliedHalf Year 2016 Oxford Pharmascience Group PLC Earnings Release - Time Not Supplied
biz.yahoo.com - September 7 at 10:11 AM
Full Year 2015 Oxford Pharmascience Group PLC Earnings Release - Time Not SuppliedFull Year 2015 Oxford Pharmascience Group PLC Earnings Release - Time Not Supplied
biz.yahoo.com - March 4 at 7:07 AM
Oxford Pharmascience Climbs on Search for Marketing PartnerOxford Pharmascience Climbs on Search for Marketing Partner
www.bloomberg.com - January 25 at 4:40 AM
Naproxen Progresses into Proof of Concept TrialsNaproxen Progresses into Proof of Concept Trials
us.rd.yahoo.com - January 14 at 11:02 AM
NSAIDs Programme & Year End Financial ReviewNSAIDs Programme & Year End Financial Review
us.rd.yahoo.com - January 14 at 11:02 AM
Successful Pilot Clinical StudySuccessful Pilot Clinical Study
us.rd.yahoo.com - January 14 at 11:02 AM
PK Results for OXPzero Naproxen vs. NaprosynPK Results for OXPzero Naproxen vs. Naprosyn
us.rd.yahoo.com - January 14 at 11:02 AM
Ibuprofen progressing to proof of concept trialIbuprofen progressing to proof of concept trial
us.rd.yahoo.com - January 14 at 11:02 AM
Initiation of Pilot Clinical Study for NaproxenInitiation of Pilot Clinical Study for Naproxen
us.rd.yahoo.com - January 14 at 11:02 AM
Proposed PlacingProposed Placing
us.rd.yahoo.com - January 14 at 11:02 AM
Grant of Share OptionsGrant of Share Options
us.rd.yahoo.com - January 14 at 11:02 AM
Posting of Circular and Notice of GMPosting of Circular and Notice of GM
us.rd.yahoo.com - January 14 at 11:02 AM
Result of GMResult of GM
us.rd.yahoo.com - January 14 at 11:02 AM
Initiation of Pilot Clinical StudyInitiation of Pilot Clinical Study
us.rd.yahoo.com - January 14 at 11:02 AM
Initiation of Pilot Clinical Study for IbuprofenInitiation of Pilot Clinical Study for Ibuprofen
us.rd.yahoo.com - January 14 at 11:02 AM
Results from Pilot Clinical Study of OXP500Results from Pilot Clinical Study of OXP500
us.rd.yahoo.com - January 14 at 11:02 AM
Preliminary PK Data & Initiation of Further StudyPreliminary PK Data & Initiation of Further Study
us.rd.yahoo.com - January 14 at 11:02 AM

SEC Filings

Oxford Pharmascience Group (LON:OXP) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Oxford Pharmascience Group (LON OXP) Stock Chart for Tuesday, January, 23, 2018

Loading chart…

This page was last updated on 1/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.